Cargando…
Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients
BACKGROUND: Biomarkers and clinical indices have been investigated for predicting mortality in patients with coronavirus disease (COVID-19). We explored the prognostic utility of procalcitonin (PCT), presepsin, and the Veterans Health Administration COVID-19 (VACO) index for predicting 30-day-mortal...
Autores principales: | Park, Mikyoung, Hur, Mina, Kim, Hanah, Lee, Chae Hoon, Lee, Jong Ho, Kim, Hyung Woo, Nam, Minjeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859553/ https://www.ncbi.nlm.nih.gov/pubmed/35177561 http://dx.doi.org/10.3343/alm.2022.42.4.406 |
Ejemplares similares
-
Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood
por: Nam, Minjeong, et al.
Publicado: (2022) -
Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients
por: Lee, Gun-Hyuk, et al.
Publicado: (2023) -
Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022) -
Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2023) -
Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
por: Kim, Hanah, et al.
Publicado: (2017)